Deal Watch: Sarepta Targets RNAi In Broad Collaboration With Arrowhead

Plus deals involving Novartis with Vyriad, Ratio and Schrödinger; Pharmanovia/Lindis, Pulmatrix/Cullgen, Entero/Journey, Roche/Flare and AlloVir/Kalaris.